Letter to the editor - "Re: Tinea labialis in a patient with Schnitzler syndrome on interleukin-1 receptor antagonist".

Velusamy B, Pincelli T, Sokumbi O

JAAD Case Rep · 2025

Grade Dletter

Key Findings

  • Expert commentary from Mayo Clinic dermatologists on anakinra-associated fungal infection risk
  • Contextualises tinea labialis as rare but clinically important opportunistic infection during IL-1 blockade
  • Supports surveillance for dermatophyte infections in Schnitzler syndrome patients on IL-1 inhibitors

Referenced in (1 disease)

ID: pmid-41542300DOI: 10.1016/j.jdcr.2025.10.071PMID: 41542300